Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs; Availability | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2022-D-1864

Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs; Availability

Documents

Comments

Description

Open

Comment Period OpensOct 24, 2022

Comment Period ClosesDec 24, 2022

Type	Title	Posted	Comments	Status
Notice	Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in Abbreviated New Drug Applications; Guidance for Industry, Availability FR Doc: 2026-05275	Mar 18, 2026

CDER

2018-827

Physicochemical and Structural (Q3)

Characterization of Topical Drug Products

Submitted in ANDAs

Open